A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer
- PMID: 11753428
- DOI: 10.1038/nsb730
A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer
Abstract
The p53 tumor suppressor requires tetramerization to function as an initiator of cell cycle arrest and/or apoptosis. Children in southern Brazil that exhibit an elevated incidence of adrenocortical carcinoma (ACC) harbor an Arg 337 to His mutation within the tetramerization domain of p53 (p53-R337H; 35 of 36 patients). The mutant tetramerization domain (p53tet-R337H) adopts a native-like fold but is less stable than the wild type domain (p53tet-wt). Furthermore, the stability of p53tet-R337H is highly sensitive to pH in the physiological range; this sensitivity correlates with the protonation state of the mutated His 337. These results demonstrate a pH-sensitive molecular defect of p53 (R337H), suggesting that pH-dependent p53 dysfunction is the molecular basis for these cases of ACC in Brazilian children.
Similar articles
-
Reversible amyloid formation by the p53 tetramerization domain and a cancer-associated mutant.J Mol Biol. 2003 Mar 28;327(3):699-709. doi: 10.1016/s0022-2836(03)00175-x. J Mol Biol. 2003. PMID: 12634062
-
Disruption of an intermonomer salt bridge in the p53 tetramerization domain results in an increased propensity to form amyloid fibrils.Protein Sci. 2005 Dec;14(12):2993-3003. doi: 10.1110/ps.051622005. Epub 2005 Oct 31. Protein Sci. 2005. PMID: 16260757 Free PMC article.
-
Tandem dimerization of the human p53 tetramerization domain stabilizes a primary dimer intermediate and dramatically enhances its oligomeric stability.J Mol Biol. 2007 Jan 26;365(4):1217-31. doi: 10.1016/j.jmb.2006.10.051. Epub 2006 Oct 21. J Mol Biol. 2007. PMID: 17113101
-
The role of tetramerization in p53 function.Oncogene. 2001 May 10;20(21):2611-7. doi: 10.1038/sj.onc.1204373. Oncogene. 2001. PMID: 11420672 Review.
-
Tetramer formation of tumor suppressor protein p53: Structure, function, and applications.Biopolymers. 2016 Nov 4;106(4):598-612. doi: 10.1002/bip.22772. Biopolymers. 2016. PMID: 26572807 Review.
Cited by
-
Tumor-Suppressor Functions of the TP53 Pathway.Cold Spring Harb Perspect Med. 2016 May 2;6(5):a026062. doi: 10.1101/cshperspect.a026062. Cold Spring Harb Perspect Med. 2016. PMID: 27141080 Free PMC article. Review.
-
The role of protonation states in ligand-receptor recognition and binding.Curr Pharm Des. 2013;19(23):4182-90. doi: 10.2174/1381612811319230004. Curr Pharm Des. 2013. PMID: 23170880 Free PMC article. Review.
-
Genetics and epigenetics of adrenocortical tumors.Mol Cell Endocrinol. 2014 Apr 5;386(1-2):67-84. doi: 10.1016/j.mce.2013.10.028. Epub 2013 Nov 9. Mol Cell Endocrinol. 2014. PMID: 24220673 Free PMC article. Review.
-
Association Between the Oligomeric Status of p53 and Clinical Outcomes in Li-Fraumeni Syndrome.J Natl Cancer Inst. 2018 Dec 1;110(12):1418-1421. doi: 10.1093/jnci/djy114. J Natl Cancer Inst. 2018. PMID: 29955864 Free PMC article.
-
Challenging issues in pediatric oncology.Nat Rev Clin Oncol. 2011 Jun 28;8(9):540-9. doi: 10.1038/nrclinonc.2011.95. Nat Rev Clin Oncol. 2011. PMID: 21709698 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Molecular Biology Databases
Research Materials
Miscellaneous